Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation

WASHINGTON, Nov. 10, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation. Danaher Beacons is a new...

Click to view original post